⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2467113 | 0.67 | — | — | |
| SCHEMBL1660786 | 0.65 | — | — | |
| SCHEMBL20337501 | 0.65 | — | — | |
| Hydrochloric Acid SCHEMBL17193183 | 0.63 | — | — | |
| SCHEMBL20657784 | 0.63 | — | — | |
| SCHEMBL4560836 | 0.60 | — | — | |
| SCHEMBL7718818 | 0.58 | — | — | |
| SCHEMBL12087547 | 0.56 | — | — | |
| SCHEMBL10768796 | 0.55 | — | — | |
| SCHEMBL9232692 | 0.54 | KMT2A (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0801561-B1 | COMPOSITION AND METHODS FOR TRANSDERMAL DELIVERY OF ACID-LABILE DRUGS | NOVEN PHARMA (US) | 2005-04-06 | — | — | EP | claimed |
| CN-110072567-A | Medical aquogel | 芬欧汇川集团 | 2019-07-30 | — | — | CN | disclosed |
| CN-106074455-A | Amorphous drug transdermal systems, methods of manufacture and stabilization | 迈兰技术公司 | 2016-11-09 | — | — | CN | disclosed |
| CN-101674816-B | Amorphous drug transdermal systems, methods of manufacture and stabilization | 迈兰技术公司 | 2016-10-26 | — | — | CN | disclosed |
| EP-2117513-A2 | POLYMER FORMULATIONS FOR DELIVERY OF BIOACTIVE AGENTS | Carbylan Biosurgery, Inc. (US) | 2009-11-18 | — | — | EP | disclosed |
| WO-2008098019-A2 | POLYMER FORMULATIONS FOR DELIVERY OF BIOACTIVE AGENTS | CARBYLAN BIOSURGERY, INC. (US) | 2008-08-14 | — | — | WO | disclosed |
| EP-0801561-B1 | COMPOSITION AND METHODS FOR TRANSDERMAL DELIVERY OF ACID-LABILE DRUGS | NOVEN PHARMA (US) | 2005-04-06 | — | — | EP | disclosed |
| EP-1235561-A2 | FAST DISSOLVING COMPOSITION WITH PROLONGED SWEET TASTE | Panacea Biotec Limited (IN) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001039749-A2 | FAST DISSOLVING COMPOSITION WITH PROLONGED SWEET TASTE | PANACEA BIOTEC LIMITED (IN) | 2001-06-07 | — | — | WO | disclosed |
| US-6024974-A | TRANSDERMAL DRUG DELIVERY | NOVEN PHARMACEUTICALS, INC. (US) | 2000-02-15 | — | — | US | disclosed |
| WO-1998053863-A2 | COMPOSITION AND METHODS FOR TRANSDERMAL DELIVERY OF ACID LABILE DRUGS | NOVEN PHARMACEUTICALS, INC. (US) | 1998-12-03 | — | — | WO | disclosed |
| US-5719197-A | DRUG DELIVERY | NOVEN PHARMACEUTICALS, INC. (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0801561-A2 | COMPOSITION AND METHODS FOR TRANSDERMAL DELIVERY OF ACID-LABILE DRUGS | NOVEN PHARMACEUTICALS, INC. (US) | 1997-10-22 | — | — | EP | disclosed |
| WO-1996040086-A2 | COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS | NOVEN PHARMACEUTICALS, INC. (US) | 1996-12-19 | — | — | WO | disclosed |
| WO-1996020699-A1 | COMPOSITION AND METHODS FOR TRANSDERMAL DELIVERY OF ACID-LABILE DRUGS | NOVEN PHARMACEUTICALS, INC. (US) | 1996-07-11 | — | — | WO | disclosed |
| US-5446070-A | Flexible, finite, bioadhesive, therapeutical agent in solid form | NOVER PHARMACEUTICALS, INC. (US) | 1995-08-29 | — | — | US | disclosed |